Active Ingredient: SERMORELIN ACETATE
Proprietary Name: GEREF
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 0.5MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020443
Product Number: 001
Approval Date: Sep 26, 1997
Applicant Holder Full Name: EMD SERONO INC
Marketing Status:
Discontinued
Patent and Exclusivity Information